Latest filing published 13 May 2015 for HTG Molecular Diagnostics, INC.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Merck Capital Ventures LLC: trading record in brief
All filings by Merck Capital Ventures LLC on record concern HTG Molecular Diagnostics, Inc. The record holds 8 filings, all for trades on 11 May 2015.
On the market, this insider has only ever bought: 1 purchase, €2.1M in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay.
The newest entry dates from 13 May 2015: a transaction, in HTG Molecular Diagnostics, Inc. The last purchase on record was published on 13 May 2015, which is 4,198 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Merck Capital Ventures LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 90,494 sharesCommon StockSEC:0001209191-15-042302:1
- 192,373 sharesCommon StockSEC:0001209191-15-042302:2
- 70,898 sharesCommon StockSEC:0001209191-15-042302:3
- 1,963 sharesCommon StockSEC:0001209191-15-042302:4
- 125,327 sharesCommon StockSEC:0001209191-15-042302:0
- 55,377 shares@ US$14.00Common StockSEC:0001209191-15-042302:5
- 52,929 shares0Common StockSEC:0001209191-15-042302:6
- 167,343 shares@ US$14.00Common StockSEC:0001209191-15-042302:7Canonical exit: 9 Aug 2015 (T+90)
8 of 8 declarations